AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10623703 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 80
Study 9181181 — intervention group
Group type: EXPERIMENTAL
Intervention: 65 mg NET-90
Number of subjects: 100
Study 9181181 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg NET-90
Number of subjects: 100
Study 8251354 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cetirizine (10 mg at night) and ranitidine (150 mg twice daily)
Number of subjects: 28
Study 8251354 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of terfenadine (120 mg twice daily) and ranitidine (150 mg twice daily)
Number of subjects: 28
Study 8251354 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine (10 mg at night)
Number of subjects: 28
Study 8251354 — intervention group
Group type: COMPARATOR
Intervention: Terfenadine (120 mg twice daily)
Number of subjects: 28
Study 2994577 — intervention group
Group type: EXPERIMENTAL
Intervention: CPA.ACNU.VCR (CNV, n = 64)
Number of subjects: 116
Study 2994577 — intervention group
Group type: EXPERIMENTAL
Intervention: ADR.ACNU.VCR (ANV, n = 52)
Number of subjects: 116
Study 29956072 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer parent support intervention
Number of subjects: 0
Study 29956072 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Patient Activation Measure‐Mental Health (P‐PAM‐MH)
Number of subjects: 0
Study 29985447 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Taekwondo (TKD) training
Number of subjects: 145
Study 29985447 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 145
Study 27018037 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 35 mg once weekly
Number of subjects: 109
Study 27018037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 25099550 — intervention group
Group type: EXPERIMENTAL
Intervention: anodal tDCS
Number of subjects: 14
Study 25099550 — intervention group
Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 14
Study 22137189 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer role play (RP)
Number of subjects: 103
Study 22137189 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patients (SP)
Number of subjects: 103
Study 22137189 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 103
Study 19882199 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope Cobalt videolaryngoscope
Number of subjects: 100
Study 19882199 — intervention group
Group type: COMPARATOR
Intervention: Conventional GlideScope videolaryngoscope
Number of subjects: 100
Study 19882199 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 100
Study 17638930 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 25 to 29.9
Number of subjects: 7599
Study 17638930 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 22.5 to 24.9
Number of subjects: 7599
Study 17638930 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI < 22.5
Number of subjects: 7599
Study 17638930 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI >= 35
Number of subjects: 7599
Study 17638930 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower BMI without edema
Number of subjects: 7599
Study 17638930 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower BMI
Number of subjects: 7599
Study 17638930 — intervention group
Group type: COMPARATOR
Intervention: Baseline BMI
Number of subjects: 7599
Study 12769445 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran intervention (60 g oat bran daily, corresponding to 20 g dietary fiber)
Number of subjects: 22
Study 12769445 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 22
Study 11106305 — intervention group
Group type: EXPERIMENTAL
Intervention: + TP (Tryptophan included)
Number of subjects: 13
Study 11106305 — intervention group
Group type: COMPARATOR
Intervention: - TP (Tryptophan not included)
Number of subjects: 13
Study 9075465 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine (0.4 mg/kg)
Number of subjects: 10
Study 9075465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 8465164 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground reaction force feedback through auditory output (experimental group)
Number of subjects: 40
Study 8465164 — intervention group
Group type: COMPARATOR
Intervention: No ground reaction force feedback (control group)
Number of subjects: 40
Study 3928015 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg vitamin K1 per week
Number of subjects: 47
Study 3928015 — intervention group
Group type: COMPARATOR
Intervention: 20.15 mg vitamin K1 per week
Number of subjects: 47
Study 3928015 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg vitamin K1 per day
Number of subjects: 47
Study 30679522 — intervention group
Group type: EXPERIMENTAL
Intervention: Circadian misalignment (simulated night shift work)
Number of subjects: 0
Study 30679522 — intervention group
Group type: COMPARATOR
Intervention: Circadian alignment (simulated day shift work)
Number of subjects: 0
Study 30679522 — intervention group
Group type: EXPERIMENTAL
Intervention: Circadian misalignment
Number of subjects: 0
Study 28829005 — intervention group
Group type: EXPERIMENTAL
Intervention: Veder Contact Method (VCM)
Number of subjects: 111
Study 28829005 — intervention group
Group type: COMPARATOR
Intervention: Care-As-Usual (Control)
Number of subjects: 111
Study 28829005 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative feedback from caregivers and managers on VCM
Number of subjects: 111
Study 25925994 — intervention group
Group type: EXPERIMENTAL
Intervention: Crenotherapy with sodium chloride sulfate hyperthermal water rich in mineral salts
Number of subjects: 60
Study 25925994 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9%
Number of subjects: 60
Study 23856575 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHa
Number of subjects: 20
Study 23856575 — intervention group
Group type: COMPARATOR
Intervention: hCG
Number of subjects: 20
Study 21616952 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based management (n = 143)
Number of subjects: 280
Study 21616952 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based management (n = 137)
Number of subjects: 280
Study 19185249 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypan blue staining in nondiabetic patients
Number of subjects: 0
Study 19185249 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypan blue staining in diabetic patients
Number of subjects: 0
Study 19185249 — intervention group
Group type: COMPARATOR
Intervention: Capsules of nondiabetic patients without trypan blue
Number of subjects: 0
Study 19185249 — intervention group
Group type: COMPARATOR
Intervention: Capsules of diabetic patients without trypan blue
Number of subjects: 0
Study 18200368 — intervention group
Group type: EXPERIMENTAL
Intervention: Global Postural Reeducation (GPR) method
Number of subjects: 20
Study 18200368 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 20
Study 15185837 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help treatment (GSH)
Number of subjects: 161
Study 15185837 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal guided self-help treatment (M-GSH)
Number of subjects: 161
Study 15185837 — intervention group
Group type: COMPARATOR
Intervention: Control condition (CC)
Number of subjects: 161
Study 10892758 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 2457
Study 10892758 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive strategy
Number of subjects: 2457
Study 9366281 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 285
Study 9366281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285
Study 1551787 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (8 weeks treatment)
Number of subjects: 32
Study 1551787 — intervention group
Group type: COMPARATOR
Intervention: Placebo (8 weeks treatment)
Number of subjects: 32
Study 1551787 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine and Placebo
Number of subjects: 32
Study 3925744 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN), 40 to 120 mg/day
Number of subjects: 19
Study 3925744 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine, 40 to 120 mg/day
Number of subjects: 19
Study 3925744 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary nitroglycerin, 200 micrograms
Number of subjects: 19
Study 3925744 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of ISDN and calcium antagonist
Number of subjects: 19
Study 30797397 — intervention group
Group type: EXPERIMENTAL
Intervention: D-PTSD class (dissociative subtype of PTSD)
Number of subjects: 258
Study 30797397 — intervention group
Group type: COMPARATOR
Intervention: Other classes (non-dissociative subtypes)
Number of subjects: 258
Study 29037516 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users (71 patients, 21.1%)
Number of subjects: 336
Study 29037516 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 336
Study 27829576 — intervention group
Group type: COMPARATOR
Intervention: eHealth
Number of subjects: 373
Study 24754314 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting injectable paliperidone palmitate (PP)
Number of subjects: 0
Study 23254945 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic stapler device
Number of subjects: 100
Study 23254945 — intervention group
Group type: COMPARATOR
Intervention: Cavitron ultrasonic surgical aspirator (CUSA)
Number of subjects: 100
Study 20582970 — intervention group
Group type: EXPERIMENTAL
Intervention: LSA2L2-type maintenance therapy
Number of subjects: 201
Study 20582970 — intervention group
Group type: COMPARATOR
Intervention: 6-mercaptopurine (6-MP)/methotrexate (MTX) with vincristine (VCR) and dexamethasone (DEX) pulse
Number of subjects: 201
Study 20582970 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall study population
Number of subjects: 201
Study 20582970 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-risk (SR) patients
Number of subjects: 201
Study 20582970 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk (HR) patients
Number of subjects: 201
Study 18839777 — intervention group
Group type: EXPERIMENTAL
Intervention: Cockcroft-Gault (CG) formula
Number of subjects: 3316
Study 18839777 — intervention group
Group type: EXPERIMENTAL
Intervention: Modification of Diet in Renal Disease (MDRD) formula
Number of subjects: 3316
Study 18839777 — intervention group
Group type: COMPARATOR
Intervention: Serum creatinine alone
Number of subjects: 3316
Study 16637755 — intervention group
Group type: EXPERIMENTAL
Intervention: General stress exposure
Number of subjects: 0
Study 16637755 — intervention group
Group type: EXPERIMENTAL
Intervention: Frustration
Number of subjects: 0
Study 16637755 — intervention group
Group type: EXPERIMENTAL
Intervention: Startle eyeblink reactions during stress
Number of subjects: 0
Study 14585938 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran 36 mg twice daily
Number of subjects: 1851
Study 14585938 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 1851
Study 10992752 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education for osteoarthritis of the knee
Number of subjects: 0
Study 8773910 — intervention group
Group type: EXPERIMENTAL
Intervention: Post‐hepatitis C liver cirrhosis
Number of subjects: 0
Study 8773910 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic liver cirrhosis
Number of subjects: 0
Study 8773910 — intervention group
Group type: COMPARATOR
Intervention: Non-cirrhotic specimens
Number of subjects: 0
Study 8773910 — intervention group
Group type: COMPARATOR
Intervention: Idiopathic portal hypertension specimens
Number of subjects: 0
Study 1312854 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (10-40 mg twice daily)
Number of subjects: 0
Study 1312854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20-40 mg twice daily)
Number of subjects: 0
Study 31493297 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied Relaxation (AR)
Number of subjects: 96
Study 31493297 — intervention group
Group type: COMPARATOR
Intervention: Stabilisation Splint (SS)
Number of subjects: 96
Study 31102396 — intervention group
Group type: COMPARATOR
Intervention: Fiber posts (Rely X, 3M‐ESPE) with composite core build‐up (Filtek Bulk Fill Posterior, 3M‐ESPE)
Number of subjects: 30
Study 31102396 — intervention group
Group type: EXPERIMENTAL
Intervention: One‐piece milled post and core from fiber reinforced composite blocks (Trilor, Bioloren)
Number of subjects: 30
Study 31102396 — intervention group
Group type: EXPERIMENTAL
Intervention: One‐piece milled post and core from hybrid ceramic disks (Ambarino, Creamed)
Number of subjects: 30
Study 27875013 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive care unit survivorship concept
Number of subjects: 17
Study 27875013 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal qualitative interviews
Number of subjects: 17
Study 26512563 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (PRD group)
Number of subjects: 67
Study 26512563 — intervention group
Group type: COMPARATOR
Intervention: Saline (PRS group)
Number of subjects: 67
Study 24494280 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture rehabilitation group (acupuncture at specific points plus comprehensive rehabilitation therapy)
Number of subjects: 120
Study 24494280 — intervention group
Group type: COMPARATOR
Intervention: Simple rehabilitation group (comprehensive rehabilitation therapy only)
Number of subjects: 120
Study 20635176 — intervention group
Group type: EXPERIMENTAL
Intervention: Harassment condition
Number of subjects: 99
Study 20635176 — intervention group
Group type: EXPERIMENTAL
Intervention: High hostility group
Number of subjects: 99
Study 20635176 — intervention group
Group type: COMPARATOR
Intervention: Nonharassment condition
Number of subjects: 99
Study 20635176 — intervention group
Group type: COMPARATOR
Intervention: Low hostility group
Number of subjects: 99
Study 21563716 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse case management and home environmental interventions
Number of subjects: 121
Study 21563716 — intervention group
Group type: COMPARATOR
Intervention: Control group interventions (visual assessment, education, bed/pillow dust mite encasings, treatment of lead‐based paint hazards)
Number of subjects: 121
Study 17388767 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture group (n = 29)
Number of subjects: 56
Study 17388767 — intervention group
Group type: COMPARATOR
Intervention: Sham control group (n = 27)
Number of subjects: 56
Study 16269592 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 64
Study 16269592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 12040140 — intervention group
Group type: EXPERIMENTAL
Intervention: Apolipoprotein E epsilon4 allele
Number of subjects: 1998
Study 12040140 — intervention group
Group type: COMPARATOR
Intervention: Control group (no epsilon4 allele)
Number of subjects: 1998
Study 10217340 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconal (Libbs Farmacêutica Ltda, São Paulo, Brazil)
Number of subjects: 24
Study 8521433 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-min active mouthrinse with toothpaste-foam combined with 10 ml of water after brushing for 2 min
Number of subjects: 7
Study 8521433 — intervention group
Group type: COMPARATOR
Intervention: 3 thorough rinsings of approximately 15 ml water each after brushing for 2 min
Number of subjects: 7
Study 2089286 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous therapy with 400 mg/day of cimetidine for 1 year
Number of subjects: 90
Study 2089286 — intervention group
Group type: COMPARATOR
Intervention: Seasonal therapy with 400 mg/day of cimetidine for 4 months a year
Number of subjects: 90
Study 511673 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive recovery (PR)
Number of subjects: 9
Study 511673 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recovery below anaerobic threshold (AR less than AT)
Number of subjects: 9
Study 511673 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recovery above anaerobic threshold (AR greater than AT)
Number of subjects: 9
Study 511673 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recovery above anaerobic threshold while breathing 100% oxygen (AR greater than AT + O2)
Number of subjects: 9
Study 30216697 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial infant products
Number of subjects: 715
Study 30216697 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified staples (maize meal and wheat flour)
Number of subjects: 715
Study 30216697 — intervention group
Group type: COMPARATOR
Intervention: Fortified staples consumers vs nonconsumers
Number of subjects: 715
Study 30216697 — intervention group
Group type: COMPARATOR
Intervention: Complementary diet nutrient densities
Number of subjects: 715
Study 30216697 — intervention group
Group type: COMPARATOR
Intervention: Calcium intakes
Number of subjects: 715
Study 27852613 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g vitamin C-enriched gelatin
Number of subjects: 8
Study 27852613 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g vitamin C-enriched gelatin
Number of subjects: 8
Study 27852613 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 8
Study 25060839 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal buprenorphine (8 mg)
Number of subjects: 12
Study 25060839 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal buprenorphine (16 mg)
Number of subjects: 12
Study 25060839 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (8/2, 8/8, 8/16, 16/4 mg)
Number of subjects: 12
Study 25060839 — intervention group
Group type: COMPARATOR
Intervention: Naloxone (4 mg)
Number of subjects: 12
Study 25060839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 25060839 — intervention group
Group type: COMPARATOR
Intervention: Heroin (100 mg)
Number of subjects: 12
Study 23623647 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone 400 mg twice daily
Number of subjects: 4628
Study 23623647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4628
Study 21720299 — intervention group
Group type: EXPERIMENTAL
Intervention: sinuforte (one dose administered daily into each half of the nasal cavity)
Number of subjects: 30
Study 19854960 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonographically guided injections of hyaluronic acid (HA)
Number of subjects: 89
Study 19854960 — intervention group
Group type: COMPARATOR
Intervention: Blind injections of hyaluronic acid (HA)
Number of subjects: 89
Study 16412748 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg of letrozole
Number of subjects: 72
Study 16412748 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of letrozole
Number of subjects: 72
Study 15260909 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine 37.5 mg b.i.d.
Number of subjects: 88
Study 15260909 — intervention group
Group type: COMPARATOR
Intervention: Dothiepin 25 mg mane followed by 50 mg nocte
Number of subjects: 88
Study 11418255 — intervention group
Group type: EXPERIMENTAL
Intervention: PPIP office‐based system implementation
Number of subjects: 748
Study 9089821 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium prophylaxis
Number of subjects: 181
Study 9089821 — intervention group
Group type: COMPARATOR
Intervention: No lithium prophylaxis
Number of subjects: 181
Study 8095383 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium (0.4 mg.kg‐1 BW)
Number of subjects: 40
Study 8095383 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium (0.08 mg.kg‐1 BW)
Number of subjects: 40
Study 3549842 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 19
Study 3549842 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline
Number of subjects: 19
Study 29503044 — intervention group
Group type: EXPERIMENTAL
Intervention: SOS‐HAE group (intervention)
Number of subjects: 200
Study 29503044 — intervention group
Group type: COMPARATOR
Intervention: Usual-practice group (control)
Number of subjects: 200
Study 27475844 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy and intracoronary administration of tirofiban (Group A)
Number of subjects: 240
Study 27475844 — intervention group
Group type: COMPARATOR
Intervention: Thrombectomy (Group B)
Number of subjects: 240
Study 27475844 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Group C)
Number of subjects: 240
Study 24930201 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus a 12-week post-exacerbation pulmonary rehabilitation (PEPR) programme
Number of subjects: 60
Study 24930201 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment without pulmonary rehabilitation (CTWPR)
Number of subjects: 60
Study 23678498 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting intervention consisting of 44 visits from the third trimester of pregnancy to the child's second birthday.
Number of subjects: 440
Study 23678498 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visiting intervention with trained clinical psychologists conducting visits.
Number of subjects: 440
Study 20127562 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose lomitapide (AEGR-733)
Number of subjects: 0
Study 20127562 — intervention group
Group type: COMPARATOR
Intervention: High-dose MTP inhibitors (not specified)
Number of subjects: 0
Study 18318082 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 0
Study 18318082 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid angioplasty with stenting (CAS)
Number of subjects: 0
Study 18318082 — intervention group
Group type: COMPARATOR
Intervention: Best medical therapy
Number of subjects: 0
Study 15942467 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9193
Study 15942467 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 9193
Study 15765619 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates
Number of subjects: 0
Study 10510989 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine polacrilex (gum)
Number of subjects: 504
Study 10510989 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal patch
Number of subjects: 504
Study 10510989 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal spray
Number of subjects: 504
Study 10510989 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaler
Number of subjects: 504